BioRestorative Therapies, Inc. (BRTX) › Cost of RevenueBioRestorative Therapies, Inc. (BRTX) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2024: $28.1K2025: $23.8K$23.8K2024Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$23.8K-15.1%2024$28.1K—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share